RFC
GNMK

Russell Frank Company’s GenMark Diagnostics, Inc GNMK Stock Holding History

Russell Frank Company’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-155
Closed -$2K – 3164
2013
Q3 		$2K Buy
+155
New +$1.66K ﹤0.01% 3369

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Russell Frank Company's GNMK Position: Q4 2013 in Review

Russell Frank Company sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2013, closing a stake of 155 shares — an estimated $2K sold.

Russell Frank Company first reported a position in GNMK in Q3 2013 and held it in 1 quarter. The position peaked at $2K in Q3 2013. 78 funds tracked by Wall St. Rank hold GNMK as of Q4 2013.

  • Russell Frank Company reported no remaining GenMark Diagnostics, Inc position as of Q4 2013 after selling out during the quarter.
  • Russell Frank Company sold 155 GenMark Diagnostics, Inc shares in Q4 2013, an estimated $2K.
  • Russell Frank Company first reported a position in GenMark Diagnostics, Inc in Q3 2013 and held it in 1 quarter.
  • Russell Frank Company's GenMark Diagnostics, Inc position peaked at $2K in Q3 2013.
  • 78 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2013.

Based on Russell Frank Company's 13F filing for Q4 2013, filed 14 Feb 2014.